Clinical Trial Supply and Logistics Market for Pharma 2024-2034: Virtual Trials and Technology Are Gaining Acceptance among Patients and Sites
10 juin 2024 08h54 HE
|
Research and Markets
Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trial Supply and Logistics Market for Pharma 2024-2034" report has been added to ResearchAndMarkets.com's offering.World revenue for the...
Animal Testing and Non-Animal Alternative Testing Global Market Opportunities and Strategies to 2035
10 juin 2024 08h12 HE
|
Research and Markets
Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Animal Testing and Non-Animal Alternative Testing Global Market Opportunities and Strategies to 2035" report has been added to ...
GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024: Insight on 15+ Drugs in Clinical Trials
07 juin 2024 03h32 HE
|
Research and Markets
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Global GPRC5D Targeting Drugs Market Opportunity and Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. In...
$43+ Billion Cell and Gene Therapy Clinical Trials Market Forecast, 2024-2034, by Therapy Type, Phase, Indication, and Region
05 juin 2024 03h41 HE
|
Research and Markets
Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy Clinical Trials Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's...
Kymanox® Announces Facility Expansion to Enhance CGxP Space and Laboratory Service Offerings
03 juin 2024 10h16 HE
|
Kymanox
King of Prussia, Pennsylvania USA, June 03, 2024 (GLOBE NEWSWIRE) -- Kymanox is pleased to announce the expansion of its device design and testing facility in King of Prussia (KOP), PA, which will...
Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy
31 mai 2024 08h36 HE
|
Ocugen
Established Medium Dose as Safe and Tolerable Dose in Current OCU410 Clinical TrialDSMB Recommends Continuing with High-Dose Cohort Dosing with Concurrent Phase 2 Dosing MALVERN, Pa., May 31, 2024 ...
Global Tetraspecific Antibodies Clinical Trials & Market Report 2024: Pioneering the Future of Cancer Treatment, Shift Towards Tetraspecific Antibodies Amidst Drug Resistance Challenges
31 mai 2024 04h48 HE
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Global Tetraspecific Antibodies Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's...
Amyloidosis Global Clinical Trials Research 2024
30 mai 2024 07h17 HE
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Amyloidosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The analyst's clinical trial...
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review 2024
30 mai 2024 07h10 HE
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The...
Global Mycosis Fungoides Clinical Trials Analysis Report 2024
30 mai 2024 04h17 HE
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Mycosis Fungoides - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offeringThe latest report offers a detailed...